Utama › Leukemia Mieloid Akut › New York › New Rochelle
Kajian klinikal Leukemia Mieloid Akut di New Rochelle, NY
13 kajian untuk Leukemia Mieloid Akut sedang mencari peserta di lokasi dalam dan sekitar New Rochelle (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Mengambil pesertaFasa 2
- North Shore University Hospital, Manhasset · 9 mi jauh
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Westchester, Harrison · 5 mi jauh
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Westchester, Harrison · 5 mi jauh
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Westchester, Harrison · 5 mi jauh
- North Shore University Hospital, Manhasset · 9 mi jauh
A Study of CRD3874-SI in People With Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison · 5 mi jauh
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- North Shore University Hospital, Manhasset · 9 mi jauh
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi jauh
A Study of Revumenib and Mezigdomide in People With Leukemia
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi jauh
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi jauh
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Westchester, Harrison · 5 mi jauh
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering West Harrison (Limited Protocol Activities), Harrison · 5 mi jauh
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi jauh
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi jauh
Kajian Leukemia Mieloid Akut di bandar lain
- Houston, TX85 kajian
- New York City, NY51 kajian
- Boston, MA44 kajian
- Seattle, WA41 kajian
- Baldwin Park, CA40 kajian
- Columbus, OH35 kajian
- Philadelphia, PA34 kajian
- Durham, NC33 kajian
- Atlanta, GA31 kajian
- Tampa, FL29 kajian
- Chicago, IL26 kajian
- Portland, OR25 kajian
Kajian lain di New Rochelle
- Kanser Payudara38 kajian
- Kanser Paru-paru Bukan Sel Kecil18 kajian
- Kanser Prostat16 kajian
- Mieloma Pelbagai14 kajian
- Kanser Pundi Kencing11 kajian
- Kanser Paru-paru11 kajian
- Kanser Endometrium11 kajian
- Kanser Metastatik10 kajian
- Kanser (semua jenis)10 kajian
- Kanser Ovari9 kajian
- Penyakit Kardiovaskular8 kajian
- Kanser Pankreas8 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.